What is the address of Dr. Hans-Georg Zmierczak, Reumatologie?

The registered office of Dr. Hans-Georg Zmierczak, Reumatologie is located at Hippoliet Lippensplein 24/A401, 9000 Gent.

Is Dr. Hans-Georg Zmierczak, Reumatologie still active?

Yes. According to the CBE (2 November 2026) Dr. Hans-Georg Zmierczak, Reumatologie is active, legal situation “Normale toestand”, started on 14 February 2011.

Is Dr. Hans-Georg Zmierczak, Reumatologie registered on Peppol?

No, Dr. Hans-Georg Zmierczak, Reumatologie is currently not registered on the Peppol network.

What is the enterprise number of Dr. Hans-Georg Zmierczak, Reumatologie?

The enterprise number of Dr. Hans-Georg Zmierczak, Reumatologie is BE0833709060.

When was Dr. Hans-Georg Zmierczak, Reumatologie founded?

Dr. Hans-Georg Zmierczak, Reumatologie was founded on 14 February 2011.

Who are the directors of Dr. Hans-Georg Zmierczak, Reumatologie?

According to the 2025 annual accounts, the directors of Dr. Hans-Georg Zmierczak, Reumatologie are: HANS-GEORG ANTON ZMIERCZAK.

Is Dr. Hans-Georg Zmierczak, Reumatologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 February 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Dr. Hans-Georg Zmierczak, Reumatologie make in 2025?

Dr. Hans-Georg Zmierczak, Reumatologie posted a profit after taxes of € 68,271 in financial year 2025.

What is the revenue of Dr. Hans-Georg Zmierczak, Reumatologie?

As a small company, Dr. Hans-Georg Zmierczak, Reumatologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 108,833.

Dr. Hans-Georg Zmierczak, Reumatologie (Private Limited)

Dossier Dr. Hans-Georg Zmierczak, Reumatologie, printed on 3 November 2026 from databakkes.be/en/0833709060/dr-hans-georg-zmierczak-reumatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. Hans-Georg Zmierczak, Reumatologie from Gent, company number BE0833709060, closed financial year 2025 with a result of € 68,271 after tax. For that financial year Dr. Hans-Georg Zmierczak, Reumatologie recorded a gross margin of € 108,833 and equity of € 341,057. Compared with financial year 2024, the result moved from € 68,950 to € 68,271. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 341,057

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 68,271

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 337,534

▲ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,833 paid out

31 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 15,606

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,739

▲ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,702

▼ 4% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 57,094 Gross margin 2022: € 57,094 First fiscal year in the series	€ 83,191 Gross margin 2023: € 83,191 ▲ 46% vs 2022 (€ 57,094) Favourable step	€ 109,453 Gross margin 2024: € 109,453 ▲ 32% vs 2023 (€ 83,191) Favourable step	€ 108,833 Gross margin 2025: € 108,833 ▼ 1% vs 2024 (€ 109,453) Unfavourable step	▼ 1%
Profit after taxes	€ 36,211 Profit after taxes 2022: € 36,211 First fiscal year in the series	€ 47,612 Profit after taxes 2023: € 47,612 ▲ 31% vs 2022 (€ 36,211) Favourable step	€ 68,950 Profit after taxes 2024: € 68,950 ▲ 45% vs 2023 (€ 47,612) Favourable step	€ 68,271 Profit after taxes 2025: € 68,271 ▼ 1% vs 2024 (€ 68,950) Unfavourable step	▼ 1%
Equity	€ 196,373 Equity 2022: € 196,373 First fiscal year in the series	€ 243,152 Equity 2023: € 243,152 ▲ 24% vs 2022 (€ 196,373) Favourable step	€ 293,620 Equity 2024: € 293,620 ▲ 21% vs 2023 (€ 243,152) Favourable step	€ 341,057 Equity 2025: € 341,057 ▲ 16% vs 2024 (€ 293,620) Favourable step	▲ 16%
Total debts	€ 8,812 Total debts 2022: € 8,812 First fiscal year in the series	€ 11,637 Total debts 2023: € 11,637 ▲ 32% vs 2022 (€ 8,812) Unfavourable step	€ 12,120 Total debts 2024: € 12,120 ▲ 4% vs 2023 (€ 11,637) Unfavourable step	€ 12,409 Total debts 2025: € 12,409 ▲ 2% vs 2024 (€ 12,120) Unfavourable step	▲ 2%
Cash	€ 156,751 Cash 2022: € 156,751 First fiscal year in the series	€ 218,665 Cash 2023: € 218,665 ▲ 39% vs 2022 (€ 156,751) Favourable step	€ 279,441 Cash 2024: € 279,441 ▲ 28% vs 2023 (€ 218,665) Favourable step	€ 337,534 Cash 2025: € 337,534 ▲ 21% vs 2024 (€ 279,441) Favourable step	▲ 21%
Retained profit	€ 183,973 Retained profit 2022: € 183,973 First fiscal year in the series	€ 230,752 Retained profit 2023: € 230,752 ▲ 25% vs 2022 (€ 183,973) Favourable step	€ 281,220 Retained profit 2024: € 281,220 ▲ 22% vs 2023 (€ 230,752) Favourable step	€ 328,657 Retained profit 2025: € 328,657 ▲ 17% vs 2024 (€ 281,220) Favourable step	▲ 17%
Dividend	€ 49,169 Dividend 2022: € 49,169 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▼ 98% vs 2022 (€ 49,169) Unchanged	€ 18,483 Dividend 2024: € 18,483 ▲ € 17,650 vs 2023 (€ 833) Unchanged	€ 20,833 Dividend 2025: € 20,833 ▲ 13% vs 2024 (€ 18,483) Unchanged	▲ 13%
Balance sheet total	€ 207,245 Balance sheet total 2022: € 207,245 First fiscal year in the series	€ 256,849 Balance sheet total 2023: € 256,849 ▲ 24% vs 2022 (€ 207,245) Unchanged	€ 307,800 Balance sheet total 2024: € 307,800 ▲ 20% vs 2023 (€ 256,849) Unchanged	€ 355,526 Balance sheet total 2025: € 355,526 ▲ 16% vs 2024 (€ 307,800) Unchanged	▲ 16%

Key figures of Dr. Hans-Georg Zmierczak, Reumatologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Hans-Georg Zmierczak, Reumatologie?

What happened at Dr. Hans-Georg Zmierczak, Reumatologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 68,271 (▼ 1% vs 2024). Source: NBB ↗
Feb 24, 2011 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jan 26, 2011 New establishment in Gent. KBO

In short

From € 36,211 profit in 2022 to € 68,271 profit in 2025.

Paid € 103,624 in corporate taxes since 2022.

Best year ever: 2024, with € 68,950 profit.

Paid out € 89,318 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

HANS-GEORG ANTON ZMIERCZAK

Dr. Hans-Georg Zmierczak, Reumatologie

Behind Dr. Hans-Georg Zmierczak, Reumatologie is HANS-GEORG ANTON ZMIERCZAK.

Directors

According to the 2025 annual accounts

HANS-GEORG ANTON ZMIERCZAK

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Hippoliet Lippensplein 24/A401

9000 Gent

2.196.190.757

Hippoliet Lippensplein 24 box A401

9000 Gent

Active since 26 January 2011

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

24 February 2011 Source: Deed ↗

ZMIERCZAK Hans-Georg Anton(vennoot) 100%

Details

Company number: 0833.709.060
VAT number: BE 0833.709.060
Registered office: Hippoliet Lippensplein 24/A401, 9000 Gent
Names & denominations: Dr. Hans-Georg Zmierczak, Reumatologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 February 2011
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗